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results in the formation of three major dimethylxanthine metabolites (paraxanthine, theobromine and theophylline) and one hydroxylated metabolite (1, 3, 7-trimethyluric acid) (Kot and Daniel 2008a) , where paraxanthine is the predominant caffeine-derived metabolite in humans and 1, 3, 7-trimethyluric acid and theophylline are determined as the major metabolites in rodents and monkeys, respectively (Berthou et al. 1992; Kot and Daniel 2008b) .
Oxidative processes are very important for living organisms. Under pathological or oxidative stress conditions reactive oxygen species (ROS) are overproduced which results in peroxidation of membrane lipids, leading to accumulation of lipid peroxides. On the other hand, oxidative stress is known to be involved in ageing and in various diseases, including diabetes mellitus, atherosclerosis, rheumatoid arthritis, Alzheimer's disease, Parkinson's disease and cancer (Metro et al. 2017) . Some contradictory evidences are available for the influence of caffeine on oxidative stress processes (Acheson et al. 2004) . It is known that some of the effects of caffeine lead to protection against cellular damage by producing beneficial antioxidant effects (Pasaoglu et al. 2011) , since caffeine has been recognized as an efficient biological antioxidant (Shi et al. 1991) . However, some data suggest that this property is observed only when caffeine acts as an effective inhibitor of lipid peroxidation, at millimolar concentrations, in rat liver microsomes (Devasagayam et al. 1996) . On the other hand, caffeine shows in vitro prooxidant effect (Gulcin 2008) and is capable of inducing oxidative damage by fostering lipid peroxidation in rat liver (Dianzani et al. 1991) . The role of caffeine in lipid peroxidation is varied and possibly depends on the dose of caffeine ingested.
Acylhydrazone derivatives are another molecular scaffold, on the basis of which new biologically active compounds can be generated. They are compounds formed from the condensation of an acylhydrazine and a carbonyl reagent. Azomethine group (-NH-N=CH-) contained in their structure is connected with carbonyl group and is responsible for the different pharmacological applications of cited compounds. Hydrazid-hydrazones have, therefore, attracted considerable attention to their wide range of biological activities (Sarıgöl et al. 2015) , including antioxidant, anticancer and cytoprotective potency (Hristova-Avakumova et al. 2017; Nikolaevskii et al. 2012) .
Microsomes are widely used test systems for investigation of the metabolic stability and metabolic profile of a large number of molecules during the drug discovery and development phases (Barcelos et al. 2014) . Microsomal liver fractions combined with the possibility of automation of incubating process are elevated to high-tech applications. High storage stability of microsomes provides an opportunity to create a human bank for hepatic fractions and to study differences in enzyme activities in the population. Correlation analysis is applied to study metabolic pathways in the context of enzymatic topology (Barcelos et al. 2014) , where malondialdehyde (MDA) is known to be the most frequently used biomarker of lipid peroxidation and oxidative stress evaluation.
In this study, based on the biological activity profiles of xanthines and acyl hydrazones, we hybridized these two ring systems into one unit thus reporting the synthesis of series novel caffeine-8-(2-thio)-propanoic hydrazid-hydrazone derivatives. Based on some literary data, in addition, we set as purpose to evaluate the effects of the newly synthesized compounds on isolated rat liver microsomes as a model of hepatotoxicity on subcellular level, applying the level of generated malondialdehyde (MDA) in the rat liver microsomes as a measure of the hepatotoxicity.
Materials and methods

Materials
All chemicals and solvents were purchased from Merck AG (Merck, Darmstadt, Germany). The chromatographic system for TLC control and purity elucidation is based on an alimunium sheets Silica gel F254 (Merck, Darmstadt, Germany), using the following mobile phases: Phase 1: 25% NH 4 OH/Acetone/CHCl 3 /CH 3 CH 2 OH (1/3/3/4) and Phase 2: H 2 O/n-butanol/CH 3 COOH (5/4/1), with detection at UV 254 nm. Yields were calculated for purified products. A Buchi 535 capillary apparatus (Switzerland) was used to determine the melting points. The IR spectra 400 -4000cm -1 were recorded on a Nicolet iS10 FT-IR Spectrometer using ATR technique with Smart iTR adapter. UV-spectra were recorded on a Jenway 6715 UV/VIS Spectrophotometer, Japan. A Bruker Spectrospin WM250 spectrometer (Faenlanden, Switzerland) was used to acquire 1 H-NMR and 13 C-NMR spectra at 250 and 75 MHz, respectively. TMS as internal standard and DMSO-d 6 were used as internal standard and solvent, respectively, all OH and NH protons were D 2 O exchangeable. The coupling constants (J) are expressed in Hertz (Hz). The mass spectra were recorded on a Dionex Ultimate 3000 RSLC Ultrasonic Liquid Chromatography System (Thermo Scientific) equipped of a six-channel SRD-3600 Degaser, a HPG-3400RS High Pressure Binary Gradient Pump, an Automatic Sample Injector WPS-3000TRS and TCC-3000RS column thermostat. The chromatographic system is connected to a Q-Exact Plus mass spectrometer (Thermo Scientific, Bremen, Germany) with Enhanced Resolution Mode enabled (up to 280,000 FWHM at m/z 200). Microanalyses, determined for C, N and H, were within ±0.4% of theoretical values and were performed on Euro EA 3000-Single, EUROVECTOR SpA analyser. All names were generated by using structure-to-name algorithm of Chem-BioDraw Ultra software, Version 11.0, CambridgeSoft.
Chemistry
Synthesis of initial intermediates 8-bromocaffeine (1), caffeine-8-(2-thio)-propanioc acid (3), methyl ester of caffeine-8-(2-thio)-propanioc acid (4) and caffeine-8-(2-thio)-propanehydrazide (5)
The starting 8-bromocaffeine (1) was obtained using oxidative bromination of caffeine according to protocol, described by Mitkov et al (Mitkov et al. 2012 ). Intermediates 3, 4 and 5 are obtained in excellent yields and purity, following the synthetic procedure published in our earlier paper (Mitkov et al. 2019 ).
2.2.2.
General procedure for syntheses of substituted N'-substituted 2- (1, 3, 3, 6, In a round-bottomed flask equipped with a reflux condenser and an electromagnetic stirrer, the hydrazide 5 (0.0032 mol) and the corresponding ketone (0.004 mol) were mixed in 50 ml of ethanol. The reaction mixture is stirred under reflux. During the reaction, the precipitation of the product begins. Reaction time is determined by exhaustion of the starting reagents (TLC monitoring in phase 2) and varies from 40 minutes to 4 hours. The reaction mixture was cooled and filtered. If necessary, the filtrate is concentrated in vacuum to 10 ml and after several hours additional amount of product is separated. The product is recrystallized from ethanol. 3176, 1701, 1655, 1601, 1538, 1445, 1159; λ max N'-(1-p-tolylethylidene)-2- (1,3,7-trimethyl-2,6-dioxo-2,3,6,7tetrahydro-1H-purin-8-ylthio) -propanehydrazide (6b) FTIR (ATR), cm -1 : 3178, 1701, 1655, 1601, 1538, 1446, 1159; λ max , nm: 216, 288 ; 1 H-NMR (DMSO-d 6 ), δ: 1.30 (3H, d, J = 6.7 Hz, -CH-CH 3 ), 2.12 (3H, s, =C-CH 3 ), 2.21 (3H, s, Ar-CH 3 ), 3.30 (s; 3H; N1-CH 3 ), 3.39 (s; 3H; N3-CH 3 ), 3.69 (s; 3H; N7-CH 3 ), 3.82 (1H, q, J = 6.7 Hz, S-CH-), 7.13 (2H, m, Ar-H), 7.43 (2H, m, Ar-H); 13 C NMR (DM-SO-d 6 ), δ: 13.1 (=C-CH 3 ), 16.1 (CH-CH 3 ), 21.3 (Ar-CH 3 ), 27.9 (N 1 -CH 3 ), 29.8 (N 3 -CH 3 ), 32.5(N 7 -CH 3 ), 33.7 (S-CH), 138.5 (C Ar -1), 125.2 (C Ar -2 and C Ar -6), 129.3 (C Ar -3 and C Ar -5), 139.8 (C Ar -6), 107.1 (C-5), 145.4 (N=C), 147.0 (C-8), 148.8 (C-4), 151.4 (C-2), 154.7 (C-6), 167.3 (CO-NH); С 20 Н 24 N 6 O 3 S (428.51); % calculated: C 56. 06, H 5.65, N 19.61, S 7.48; and % found: C 56.03, H 5.45, N 19.47, S 7.20 . LC-MS (70 eV) m/z (%): 429 (M+1), 430 (M+2).
N'-(1-(4-methoxyphenyl)ethylidene)-2- (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio) propanehydrazide (6c) FTIR (ATR), cm -1 : 3171, 1701, 1652, 1603, 1538, 1446, 1159; λ max , nm: 216,294 ; 1 H-NMR (DMSO-d 6 ), δ: 1.30 (3H, d, J = 6.7 Hz, -CH-CH 3 ), 2.12 (3H, s, =C-CH 3 ), 3.30 (s; 3H; N1-CH 3 ), 3.39 (s; 3H; N3-CH 3 ), 3.69 (s; 3H; N7-CH 3 ), 3.79 (3H, s, OCH 3 ), 3.82 (1H, q, J = 6.7 Hz, S-CH-), 7.40 (2H, m, Ar-H), 7.28 (2H, m, Ar-H); 13 C NMR (DMSO-d 6 ), δ: 13.1 (=C-CH 3 ), 16.1 (CH-CH 3 ), 55.5 (OCH 3 ), 27.9 (N 1 -CH 3 ), 29.8 (N 3 -CH 3 ), 32.5(N 7 -CH 3 ), 33.7 (S-CH), 138.5 (C Ar -1), 128.7 (C Ar -2 and C Ar -6), 114.1 (C Ar -3 and C Ar -5), 160.4 (C Ar -6), 107.1 (C-5), 145.4 (N=C), 147.0 (C-8), 148.8 (C-4), 151.4 (C-2), 154.7 (C-6), 167.3 (CO-NH); С 20 Н 24 N 6 O 4 S (444.51); % calculated: C 54. 04, H 5.44, N 18.91, S 7.21; and % found: C 54.03, H 5.42, N 18.87, S 7.18 (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio) propanehydrazide (6d) FTIR (ATR), cm -1 : 3176, 1699, 1654, 1612, 1538, 1489, 1447, 1157; λ max N'-(1-(4-hydroxyphenyl)propylidene)-2- (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio) propanehydrazide (6e) FTIR (ATR), cm -1 : 3274, 3173, 1694, 1652, 1607, 1538, 1514, 1447, 1157; λ max N'-(1-phenylpropylidene)-2- (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio) propanehydrazide (6f) FTIR (ATR), cm -1 : 3175, 1700, 1654, 1603, 1539, 1446, 1159; λ max , nm: 216, 288 29.8 (N 3 -CH 3 ), 32.5(N 7 -CH 3 ), 33.7 (S-CH), 137.1 (C Ar -1), 126.9 (C Ar -2 and C Ar -6), 128.7 (C Ar -3 and C Ar -5), 129.8 (C Ar -6), 107.1 (C-5), 157.4 (N=C), 147.0 (C-8), 148.8 (C-4), 151.4 (C-2), 154.7 (C-6), 167.3 (CO-NH); С 20 Н 24 N 6 O 3 S (428.51); % calculated: C 56. 06, H 5.65, N 19.61, S 7.48; and % found: C 56.01, H 5.55, N 19.57, S 7.35 . LC-MS (70 eV) m/z (%): 429 (M+1), 430 (M+2).
N'-(1-phenylbutylidene)-2- (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio) propanehydrazide (6g) FTIR (ATR), cm -1 : 3179, 1699, 1654, 1603, 1538, 1447, 1159; λ max , nm: 216, 306 ; 1 H-NMR (DMSO-d 6 ), δ: 1.00 (3H, t, J = 6.7 Hz, -CH 2 -CH 3 ), 1.33 (3H, d, J = 6.7 Hz, -CH- N'-((4-methoxyphenyl)(phenyl)methylene)-2- (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio) propanehydrazide (6h) FTIR (ATR), cm -1 : 3272, 3175, 1699, 1652, 1603, 1538, 1445, 1157; λ N'-(2-methyl-1-phenylpropylidene)-2- (1,3,7-trimethyl-2,6dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio) propanehydrazide (6i) FTIR (ATR), cm -1 : 3218, 1694, 1655, 1607, 1522, 1465, 1158; λ max 
Biological evaluation
Animals
Male Wistar rats (body weight 200-250 g) were used. The rats were housed in plexiglass cages (3 per cage) in a 12/12 light/dark cycle, under standard laboratory conditions (ambient temperature 20 °C ± 2 °C and humidity 72 % ± 4 %) with free access to water and standard pelleted rat food 53-3, produced according to ISO 9001:2008.
Animals were purchased from the National Breeding Center, Sofia, Bulgaria. At least 7 days of acclimatization was allowed before the commencement of the study. The health was monitored regularly by a veterinary physician. The vivarium (certificate of registration of farm № 0072/01.08.2007) was inspected by the Bulgarian Drug Agency in order to check the husbandry conditions (№ A-11-1081/03.11.2011). All performed procedures were approved by the Institutional Animal Care Committee and made according Ordinance № 15/2006 for humaneness behavior to experimental animals.
Isolation and incubation of microsomes
The liver microsomes were isolated by ultracentrifugation, using Beckman L8-M centrifuge with a 70Ti rotor, for 1 hour, following Guengerich's methodology (Guengerich 1989) . The protein measurement was carried out using method of Lowry et al (Lowry et al. 1951) .
Measurement of malondialdehyde (MDA) in isolated rat microsomes
The concentration of MDA was determined spectrophotometrically at 535 nm by the Debby& Gutier method (Deby and Goutier 1990) .
Statistical analysis
Statistical analysis was performed using statistical program "MEDCALC". Results are expressed as mean ± SEM for 7 experiments. The significance of the data was assessed using the nonparametric Mann-Whitney test. Values of P ≤ 0.05; P ≤ 0.01 and P ≤ 0.001 were considered statistically significant. Three parallel samples were used.
Results and discussion
Chemistry
The synthesis of described hydrazid-hydrazones was carried out following a procedure outlined on Scheme 1. The starting 8-bromocaffeine (1) was obtained using oxidative bromination of caffeine according to protocol, described by Mitkov et al (Mitkov et al. 2012) . Intermediates 3, 4 and 5 are obtained in excellent yields and purity, following the synthetic procedure published in our earlier paper (Mitkov et al. 2019) . The final products 6a-i were prepared via condensation of the hydrazide 5 with the corresponding ketone in a molar ratio of 1: 1.25 in an ethanol medium. The compounds 6a-i were obtained with purity (within ± 0.4% of the calculated value), evaluated by microanalysis. The structures of the target compounds were confirmed on the basis of their FT-IR, 1 H-, 13 C NMR and mass spectral data. The physical data of all synthesized compounds 6a-i are given in Table 1 .
In the performed spectral analysis a slight discrepancy in the expected and the measured IR spectra for compound 6d was observed. This may be due to the intramolecular hydrogen bond which may be found in 6d resulting in formation of a stable 6-membered ring as shown in structure below (Figure 1) .
Thus no absorption bands due to the free O-H stretching vibration were found in the infrared spectra of any of the salicylidene anilines. Instead, a broad, weak band having some fine structure is found in the region from 2700 to 3100 cm -1 as is the case with 6d.
Also, a slight absorption band at 1157-1159 cm -1 , which is not observed in the spectra of starting xanthines 1 and 3, is clearly visible in the spectra of studied compounds 6a-i. We consider this band to be due to N-N stretching vibration from the hydrazide residue. The identifications of this stretching vibration is a difficult task, but there is literary evidence to support our assumption (Bharanidharan et al. 2017; Gulaczyk et al. 2003) .
Prediction of toxicity and drug-likeness
The toxicity and drug-likeness of compounds were predict by using PROTOX II ("ProTox-II") web server. The ProTox-II web server provides several advantages over existing computational models. It includes both chemical and molecular target knowledge. The prediction scheme is classified into different levels of toxicity such as oral toxicity as well as organ toxicity (hepatotoxicity). ProTox-II incorporates molecular similarity and pharmacophore based fragment propensities (Banerjee et al. 2018b ). An MDDRlike rule published by Oprea et al. (Oprea 2000; Oprea et al. 2000) was applied for drug-likeness evaluation of the newly synthesized compounds. The values of the calculated descriptors (Table 2) indicate that all compounds can be defined as "drug-like" as they fulfill the criteria of drug-likeness which includes the MDRP filter. MDDR-like rule (Oprea 2000; Oprea et al. 2000) is using as molecular descriptors in the means of number of rings, number of rigid bonds and number of rotatable bonds, whit the probability of finding a 'druglike' compound being higher in the ranges of No. Rings ≥ 3, No. Rigid bonds ≥ 18, No. Rotatable bonds ≥ 6, while the probability of finding a 'nondrug-like' compound being higher in the ranges of No.Rings ≤ 2, No. Rigid bonds ≤ 17, No. Rotatable bonds ≤ 5.
Drug-induced hepatotoxicity is a significant cause of acute liver failure and one of the major reasons for the withdrawal of drugs from the market. Drug-induced liver injury (DILI) is either a chronic process or a rare event. However, prediction of DILI is important and one of the safety concerns for the drug developers, regulators and clinicians (Liu et al. 2015) . The data for the prediction of DILI are taken from DILIrank (Chen et al. 2016 ) and the NIH LiverTox database (Thakkar et al. 2018) . The Pro-Tox-II hepatotoxicity prediction model has a balanced accuracy of 82.00% on cross validation and 86.00% on exter-nal validation. The AUC-ROC scores of cross-validation and external validation are 0.86 and 0.91 respectively. The kappa value is 0.69 for the model (Banerjee et al. 2018b ). The model applied to predict hepatotoxicity is described in detail in the literature (Banerjee et al. 2018a) .
The results of prediction are shown in Table 3 . All the compounds appeared to be low toxic belonging to the category III and IV of GHS (Globally Harmonized System of Classification and Labeling of Chemicals) categories ("GHS-unece").
Prediction of substrate/metabolite specificity
The evaluated set of compounds was subjected to a prediction of substrate/metabolite specificity, using an SMP web-service (Bezhentsev et al. 2016) for in silico prediction of the substrate/metabolite specificity. This service provides the possible interaction of the tested group of compounds with 18 cytochrome P450 and UGT isoforms: CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4, UG-T1A10, UGT1A1, UGT2B7, UGT1A7, UGT2B15, UG-T1A8, UGT1A4, UGT2B17, UGT2B10, UGT1A3, UG-T1A9, UGT1A6, UGT2B4; defined as the most probable targets. The performed prediction is based on the PASS algorithm and is defined in the software Multilevel Neighborhoods of Atoms (MNA) descriptors. The obtained data for the substrate based predictions are presented in Table 4 for compounds 6a-i, 3, 4, 5 and Caffeine. The results for the corresponding metabolite based predictions for the same set of structures are presented in Table 5 . Based on the obtained data we consider the tested compounds to perform most probably CYP4501A2 substrate activity.
In vitro evaluation of effect on isolated rat liver microsomes
It is a well known fact that Caffeine is metabolized by CY-P1A2. It is of interest to establish whether during their metabolism the the newly synthesized caffeine derivatives 6a-i would be biotransformed into reactive metabolites and by this to reveal possible pro-oxidative properties. Thus we decided to evaluate their effect on isolated rat liver microsomes, as an in vitro system, which contains most of the isoforms of the cytochrome P450 system.
Administered alone, all of the tested compounds didn't reveal statistically significant pro-oxidant effects on isolated rat liver microsomes ( Figure 2 ). Caffeine (as positive control) also didn't induce lipid peroxidation in statistically significant manner on isolated microsomes.
Conclusion
The present study describes the synthesis of series new caffeine-8-(2-thio)-propanoic hydrazid-hydrazone derivatives which are subjected to in silico prediction of substrate/ metabolite specificity. Based on the obtained data we consider the tested compounds to perform most probably as CYP1A2 substrates. The newly synthesized hydrazid-hydrazones were also subjected to in silico prediction of the Drug Induced Liver Injury (DILI). The prediction for all compounds indicates that they would not show hepatotoxicity. The carried out in vitro studies confirmed that the tested compounds didn't reveal statistically significant hepatotoxicity, due to pro-oxidant effects, on sub-cellular (isolated rat liver microsomes) level. These results underlined the tested molecules as promising structures for design of future compounds with low hepatotoxicity. 2 . Effect of the hydrazid-hydrazones 6a-i, administered alone at concentration 100 µM, on isolated rat liver microsomes.
